Clinical Trials Directory

Trials / Completed

CompletedNCT00403507

Exercise Treatment of Mild-Stage Probable Alzheimer's Disease

Physical Activity as a Treatment of Mild-Stage Probable Alzheimer's Disease

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
79 (estimated)
Sponsor
Intermountain Health Care, Inc. · Academic / Other
Sex
All
Age
65 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine if participation in an exercise program helps memory loss from getting worse, and if it improves daily functioning and attitudes of those with probable Alzheimer's disease. It will involve participation of both the person with memory loss and someone who knows their daily activities (e.g., husband, wife, adult child, or caregiver).

Detailed description

Currently, there is no cure for the memory loss associated with Alzheimer's disease, though some medications can help it from getting worse. The research study will help to answer the question if participation in an exercise program helps memory loss from getting worse, and if it improves daily functioning and attitudes of those with probable Alzheimer's disease. It will involve participation of both the person with memory loss and someone who knows their daily activities. The research study is a randomized-control trial: some participants will be picked to participate in the exercise program, while others will not. Their memory, thinking abilities, activities, and attitudes will be measured at baseline and follow-up assessment 5-6 months later. Participants are in good health, and are treated with a cholinesterase inhibitor for memory loss (standard treatment).

Conditions

Interventions

TypeNameDescription
BEHAVIORALParticipation in a monitored exercise programNo contact with control group during 20 weeks.
BEHAVIORALPersonalized aerobic and strength training.Three-days per week for 20 weeks at hospital gym under supervision of exercise specialist.

Timeline

Start date
2006-10-01
Primary completion
2009-10-01
Completion
2009-10-01
First posted
2006-11-23
Last updated
2011-05-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00403507. Inclusion in this directory is not an endorsement.